Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Transplantation Proceedings|August 7, 2016
Endocan Concentration and Chronic Inflammatory Process Among Heart Transplant RecipientsP Przybylowski, G Wasilewski, E Koc-Żórawska, et al.
Transplantation Proceedings|September 5, 2018
Kallistatin Concentration and Hypertension in Heart Transplant RecipientsP Przybyłowski, G Wasilewski, E Koc-Żórawska, et al.
Transplantation Proceedings|September 5, 2018
Vitamin D Concentration in Patients After Heart and Kidney TransplantationP Przybyłowski, G Wasilewski, E Koc-Żórawska, et al.
Transplantation Proceedings|November 9, 2014
Effect of immunosuppressive therapy on the serum fatty acids of phospholipids fraction in patients after heart transplantationM Wilusz, G Wasilewski, P Przybyłowski, et al.
Transplantation Proceedings|November 9, 2014
YKL-40, a novel marker of cardiovascular complications, is related to kidney function in heart transplant recipientsP Przybyłowski, L Janik, G Wasilewski, et al.
Transplantation Proceedings|November 9, 2014
Inadequate blood pressure control in orthotopic heart transplant: is there a role of kidney function and immunosuppressive regimen?G Wasilewski, P Przybylowski, L Janik, et al.
Transplantation Proceedings|November 9, 2014
Dopamine and noradrenaline are unrelated to renalase, heart rate, and blood pressure in heart transplant recipientsG Wasilewski, P Przybyłowski, L Janik, et al.
Transplantation Proceedings|November 9, 2014
Fibroblast growth factor 23 and Klotho as cardiovascular risk factors in heart transplant recipientsP Przybylowski, G Wasilewski, L Janik, et al.
Transplantation Proceedings|November 9, 2014
Zonulin and iron metabolism in heart transplant recipientsP Przybyłowski, E Nowak, L Janik, et al.
Transplantation Proceedings|November 9, 2014
Growth differentiation factor 15 is related to anemia and iron metabolism in heart allograft recipients and patients with chronic heart failureP Przybyłowski, G Wasilewski, H Bachorzewska-Gajewska, et al.
Pageof 2